Heidie Huyck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Heidie Huyck has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Gloria S. Pryhuber
Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA
28 shared publications - Ravi S. Misra
University of Rochester Medical Center , Rochester, New York
7 shared publications - Gail H. Deutsch
Center for Respiratory Biology and Therapeutics Seattle Children's Research Institute Seattle Washington USA
6 shared publications - Gautam Bandyopadhyay
University of Rochester School of Medicine and Dentistry
5 shared publications Jeffrey Purkerson
URMC HuBMAP Lung TMC Seattle Children's Hospital Department of Pathology URMC Pryhuber Lab University of Rochester University of Rochester Medical Center University of Washington
5 shared publicationsRavi Misra
5 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (28) , eaec3544
Multiscale metabolic mapping of lung tissue via coregistered mass spectrometry and nonlinear optical imaging
The lung is a highly heterogeneous organ that is composed of numerous microanatomical units, each essential for maintaining intricate functions that work in concert. Disruptions in the molecular and cellular mechanisms can cause tissue fibrosis, inflammation, and severe breathing difficulties, which are common characteristics of the disease of prematurity, bronchopulmonary dysplasia (BPD). BPD’s molecular changes are not well understood, and this has hindered effective diagnosis and treatment. Here, we present a multimodal imaging workflow for detailed molecular and metabolic characterization of lung tissue at multiple spatial scales. We also developed a hierarchical multimodal registration network for precise coregistration of the data from each modality. Our results show that this approach can reveal previously unknown metabolic changes in distinct functional tissue units affected by disease, including altered lipid distributions, reduced optical redox states, and collagen remodeling. This multimodal approach provided detailed maps of molecular shifts occurring in distinct microanatomical features that, when adopted to interrogate this and other tissue types, has the potential to enable the discovery of new therapeutics.
- 10 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (28) , eaec3544
Open AccessMultiscale metabolic mapping of lung tissue via coregistered mass spectrometry and nonlinear optical imaging
The lung is a highly heterogeneous organ that is composed of numerous microanatomical units, each essential for maintaining intricate functions that work in concert. Disruptions in the molecular and cellular mechanisms can cause tissue fibrosis, inflammation, and severe breathing difficulties, which are common characteristics of the disease of prematurity, bronchopulmonary dysplasia (BPD). BPD’s molecular changes are not well understood, and this has hindered effective diagnosis and treatment. Here, we present a multimodal imaging workflow for detailed molecular and metabolic characterization of lung tissue at multiple spatial scales. We also developed a hierarchical multimodal registration network for precise coregistration of the data from each modality. Our results show that this approach can reveal previously unknown metabolic changes in distinct functional tissue units affected by disease, including altered lipid distributions, reduced optical redox states, and collagen remodeling. This multimodal approach provided detailed maps of molecular shifts occurring in distinct microanatomical features that, when adopted to interrogate this and other tissue types, has the potential to enable the discovery of new therapeutics.
- Open Access
- 6 June 2026
- Published by Springer Nature
703 and 704. Whole Blood Peripheral Blood Mononuclear Cell (PBMC) Isolation, Freezing and Thawing. LungMAP HTC SOP v1
Purpose and Scope of the Procedure or Laboratory Assay Scope: To outline the retrieval of peripheral blood mononuclear cells (PBMC), from whole blood collected in anticoagulant, using Ficoll-Hypaque density gradient centrifugation. This protocol was used to isolate PBMC for samples received for LungMAP HTC and HuBMAP MOSDAP Project. Scientific Principles: Human Peripheral Blood Mononuclear cells (PBMCs) and platelets have a lower density than Ficoll-Hypaque (1.077 g/L) and are separated from higher density granulocytes and red blood cells when centrifuged after either under or overlaying the diluted blood on the Ficoll-Hypaque layer. Blood from young infants may contain immature red blood cells that may contaminate the upper buffy coat layer after centrifugation. The contaminating RBC may be removed from the infant buffy coat by a second Ficoll-Hypaque centrifugation step. However, since premature infant blood volumes are so small, optimizing the yield of PBMCs/ml of collected blood is critical. So a second ficoll step is not recommended. An RBC lysis step and an anti-RBC surface marker (CD252) will be used to remove and identify in flow cytometry those RBC not removed from the cell sample. To retain cellular integrity, we recommend that cells be frozen at a slow controlled rate of minus one degree Celsius per minute in cryoprotectant medium containing 10% dimethylsulfoxide (DMSO). Use of 90% FBS improves post-thaw viability in our experience. The DMSO acts to prevent ice crystal formation during the slow freezing process, maintaining cell viability. Some cell types such as PBMC may be stored short term (less than one week) at -800C or long term in a liquid nitrogen freezer. For maximum recovery and viability upon thawing, cells should be healthy prior to freezing. Successful cell recovery from the frozen state requires rapid but gentle thawing of the cells followed by immediate dilution and removal of cryoprotectant medium from the cells. Note the protocol suggesting thawing only 1-2 vials at a time and initial slow, 1-2 drop, addition of buffer to avoid shocking the cells.
- 6 June 2026
- Published by Springer Nature
Open Access703 and 704. Whole Blood Peripheral Blood Mononuclear Cell (PBMC) Isolation, Freezing and Thawing. LungMAP HTC SOP v1
Purpose and Scope of the Procedure or Laboratory Assay Scope: To outline the retrieval of peripheral blood mononuclear cells (PBMC), from whole blood collected in anticoagulant, using Ficoll-Hypaque density gradient centrifugation. This protocol was used to isolate PBMC for samples received for LungMAP HTC and HuBMAP MOSDAP Project. Scientific Principles: Human Peripheral Blood Mononuclear cells (PBMCs) and platelets have a lower density than Ficoll-Hypaque (1.077 g/L) and are separated from higher density granulocytes and red blood cells when centrifuged after either under or overlaying the diluted blood on the Ficoll-Hypaque layer. Blood from young infants may contain immature red blood cells that may contaminate the upper buffy coat layer after centrifugation. The contaminating RBC may be removed from the infant buffy coat by a second Ficoll-Hypaque centrifugation step. However, since premature infant blood volumes are so small, optimizing the yield of PBMCs/ml of collected blood is critical. So a second ficoll step is not recommended. An RBC lysis step and an anti-RBC surface marker (CD252) will be used to remove and identify in flow cytometry those RBC not removed from the cell sample. To retain cellular integrity, we recommend that cells be frozen at a slow controlled rate of minus one degree Celsius per minute in cryoprotectant medium containing 10% dimethylsulfoxide (DMSO). Use of 90% FBS improves post-thaw viability in our experience. The DMSO acts to prevent ice crystal formation during the slow freezing process, maintaining cell viability. Some cell types such as PBMC may be stored short term (less than one week) at -800C or long term in a liquid nitrogen freezer. For maximum recovery and viability upon thawing, cells should be healthy prior to freezing. Successful cell recovery from the frozen state requires rapid but gentle thawing of the cells followed by immediate dilution and removal of cryoprotectant medium from the cells. Note the protocol suggesting thawing only 1-2 vials at a time and initial slow, 1-2 drop, addition of buffer to avoid shocking the cells.
- Open Access
- 12 December 2025
- Published by Springer Nature
Precision Cut Lung Slices (PCLS) as ex vivo Human Lung Tissue Model of Cellular Senescence Assessed by Multi-Omic Modalities v1
This protocol outlines the experimental workflow for evaluating the efficacy of senescence inducers and senotherapeutic / senolytic compounds in modulating the senescence-associated secretory phenotype (SASP) using precision-cut lung slices (PCLS) as an ex vivo model system. PCLS retain the native tissue architecture and cell-type complexity of the lung, making them a relevant multi-cellular platform to study spatial and functional responses of lung tissue to pharmacological agents. Version 1 of the protocol outlines: Ex vivo induction of senescence by irradiation of PCLS using defined doses (e.g., 5–10 Gy) to model DNA damage-induced senescence and inflammatory activation. Application of senolytic drug treatment (e.g., Dasatinib, Quercetin and Fisetin, or other candidate compounds) administered after recovery from irradiation. Collection of PCLS supernatants for secretome profiling via Luminex multiplex cytokine immunoassays, focused on senescence-associated secretory phenotype (SASP) factors. Recovery and preservation of PCLS tissue following senescence induction / inhibition for 1) RNA extraction and NanoString nCounter transcriptomic profiling, targeting genes involved in senescence, DNA damage response, and immune modulation, 2) collection of supernatants for secretome profiling via Luminex multiplex cytokine immunoassays, and 3) fixation, embedding and sectioning for histochemistry, mutiplexed immunofluorescence (MxIF) and/or spatial transcriptomics.
- 12 December 2025
- Published by Springer Nature
Open AccessPrecision Cut Lung Slices (PCLS) as ex vivo Human Lung Tissue Model of Cellular Senescence Assessed by Multi-Omic Modalities v1
This protocol outlines the experimental workflow for evaluating the efficacy of senescence inducers and senotherapeutic / senolytic compounds in modulating the senescence-associated secretory phenotype (SASP) using precision-cut lung slices (PCLS) as an ex vivo model system. PCLS retain the native tissue architecture and cell-type complexity of the lung, making them a relevant multi-cellular platform to study spatial and functional responses of lung tissue to pharmacological agents. Version 1 of the protocol outlines: Ex vivo induction of senescence by irradiation of PCLS using defined doses (e.g., 5–10 Gy) to model DNA damage-induced senescence and inflammatory activation. Application of senolytic drug treatment (e.g., Dasatinib, Quercetin and Fisetin, or other candidate compounds) administered after recovery from irradiation. Collection of PCLS supernatants for secretome profiling via Luminex multiplex cytokine immunoassays, focused on senescence-associated secretory phenotype (SASP) factors. Recovery and preservation of PCLS tissue following senescence induction / inhibition for 1) RNA extraction and NanoString nCounter transcriptomic profiling, targeting genes involved in senescence, DNA damage response, and immune modulation, 2) collection of supernatants for secretome profiling via Luminex multiplex cytokine immunoassays, and 3) fixation, embedding and sectioning for histochemistry, mutiplexed immunofluorescence (MxIF) and/or spatial transcriptomics.
- Open Access
- 6 December 2025
- Published by Springer Nature
618.1_Lung MAP HTC Agarose Inflation of Non-fixed Human Lung Tissue, includes CMC embedding. v1
This protocol was developed by the Lung MAP HTC - BioRepository for Investigation of Neonatal Diseases of the Lung (BRINDL) Its purpose and scope is to agarose inflate all or a portion of a lung lobe for later potential use in several preservation or experimental methods. These include five potential downstream Processes of Agarose Inflated Lung: - Formalin Fixed Paraffin Embedded - Paraformaldehyde Fixed Sucrose Protected OCT Frozen - Un-Fixed OCT Embedded Frozen - Un-Fixed CMC Embedded Frozen - Precision Cut Lung Slices (PCLS) Cell culture suitable agarose (see Materials) is prepared in DMEM cell culture media for potential metabolic support of the agarose inflated tissue. The protocol is written for human lung lobes but can be scaled to organs of other species.
- 6 December 2025
- Published by Springer Nature
Open Access618.1_Lung MAP HTC Agarose Inflation of Non-fixed Human Lung Tissue, includes CMC embedding. v1
This protocol was developed by the Lung MAP HTC - BioRepository for Investigation of Neonatal Diseases of the Lung (BRINDL) Its purpose and scope is to agarose inflate all or a portion of a lung lobe for later potential use in several preservation or experimental methods. These include five potential downstream Processes of Agarose Inflated Lung: - Formalin Fixed Paraffin Embedded - Paraformaldehyde Fixed Sucrose Protected OCT Frozen - Un-Fixed OCT Embedded Frozen - Un-Fixed CMC Embedded Frozen - Precision Cut Lung Slices (PCLS) Cell culture suitable agarose (see Materials) is prepared in DMEM cell culture media for potential metabolic support of the agarose inflated tissue. The protocol is written for human lung lobes but can be scaled to organs of other species.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (5) , L570-L582
Sorted-cell proteomics reveals an AT1-associated epithelial cornification phenotype and suggests endothelial redox imbalance in human bronchopulmonary dysplasia
The study is the first to perform proteomics on sorted pulmonary epithelial and endothelial populations from bronchopulmonary dysplasia (BPD) and age-matched control human donors. We identified an increase in cornification-associated proteins in BPD (e.g., SCEL and LMO7), and evidenced the presence of multilayered structures unique to BPD alveolar regions, associated with alveolar type 1 (AT1) cells. By changing the nature and/or biomechanical properties of the epithelium, these structures may alter the behavior of other alveolar cell types potentially contributing to the arrested alveolarization observed in BPD. Finally, our data suggest the modulation of cell proliferation and redox homeostasis in BPD providing potential mechanisms for the reduced vascular growth associated with BPD.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (5) , L570-L582
Sorted-cell proteomics reveals an AT1-associated epithelial cornification phenotype and suggests endothelial redox imbalance in human bronchopulmonary dysplasia
The study is the first to perform proteomics on sorted pulmonary epithelial and endothelial populations from bronchopulmonary dysplasia (BPD) and age-matched control human donors. We identified an increase in cornification-associated proteins in BPD (e.g., SCEL and LMO7), and evidenced the presence of multilayered structures unique to BPD alveolar regions, associated with alveolar type 1 (AT1) cells. By changing the nature and/or biomechanical properties of the epithelium, these structures may alter the behavior of other alveolar cell types potentially contributing to the arrested alveolarization observed in BPD. Finally, our data suggest the modulation of cell proliferation and redox homeostasis in BPD providing potential mechanisms for the reduced vascular growth associated with BPD.
- Open Access
- 20 August 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (8) , 318
Dysfunctional Electron Transport Chain Assembly in COXPD8
Combined oxidative phosphorylation deficiency type 8 (COXPD8) is an autosomal recessive mitochondrial disorder caused by a mutation of the nuclear encoded mitochondrial alanyl-tRNA synthetase gene (AARS2). Clinical manifestations of COXPD8 include lethal infantile hypertrophic cardiomyopathy, pulmonary hypoplasia, generalized muscle weakness, and neurological involvement. We report a patient with COXPD8 caused by two mutations in the AARS2 gene. The c.1738 C>G mutation has not been previously reported, while the c.2872 C>T mutation has been associated with pulmonary hypoplasia and hypertrophic cardiomyopathy. Cardiac tissue, obtained through the LungMAP program, showed that, compared to other patients of similar ages, these two mutations affect not only the assembly of functional monomeric complexes (Cx) I and IV of the electron transport chain (ETC) but also limit the formation of respiratory supercomplexes. This patient had altered expression of some ETC proteins but normal expression of several enzymes of the tricarboxylic acid cycle. We also show that one of the control/comparison patients had an undiagnosed ETC Cx IV deficiency. In conclusion, our data demonstrate that the two mutations of the AARS2 gene are associated with failed assembly of Cx I and Cx IV and reduced formation of respiratory supercomplexes of the ETC, likely leading to acute bioenergetic stress.
- 20 August 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (8) , 318
Open AccessDysfunctional Electron Transport Chain Assembly in COXPD8
Combined oxidative phosphorylation deficiency type 8 (COXPD8) is an autosomal recessive mitochondrial disorder caused by a mutation of the nuclear encoded mitochondrial alanyl-tRNA synthetase gene (AARS2). Clinical manifestations of COXPD8 include lethal infantile hypertrophic cardiomyopathy, pulmonary hypoplasia, generalized muscle weakness, and neurological involvement. We report a patient with COXPD8 caused by two mutations in the AARS2 gene. The c.1738 C>G mutation has not been previously reported, while the c.2872 C>T mutation has been associated with pulmonary hypoplasia and hypertrophic cardiomyopathy. Cardiac tissue, obtained through the LungMAP program, showed that, compared to other patients of similar ages, these two mutations affect not only the assembly of functional monomeric complexes (Cx) I and IV of the electron transport chain (ETC) but also limit the formation of respiratory supercomplexes. This patient had altered expression of some ETC proteins but normal expression of several enzymes of the tricarboxylic acid cycle. We also show that one of the control/comparison patients had an undiagnosed ETC Cx IV deficiency. In conclusion, our data demonstrate that the two mutations of the AARS2 gene are associated with failed assembly of Cx I and Cx IV and reduced formation of respiratory supercomplexes of the ETC, likely leading to acute bioenergetic stress.
- Open Access
- 3 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Three dimensional multiscalar neurovascular nephron connectivity map of the human kidney across the lifespan
The human kidney maintains homeostasis through a complex network of up to a million nephrons, its fundamental tissue units. Using innovative tissue processing and light sheet fluorescence microscopy, we mapped the 3D neurovascular connectivity of nephrons to understand how their structural organization enables coordinated functions like filtration, absorption, and blood pressure regulation. Our analysis revealed developmental changes in glomerular orientation, density, volume, and innervation from birth through aging. We discovered an extensive nerve network connecting different nephron segments and organizing glomeruli into distinct communities. These communities are linked through “mother glomeruli” that serve as control centers, creating a repeating pattern throughout the cortex. This sophisticated neural organization, which is underdeveloped in newborn kidneys and disrupted in conditions like diabetes and hydronephrosis, appears to facilitate synchronized responses to maintain fluid balance. The findings provide insights into how the kidney’s structural architecture enables coordinated function across its numerous nephrons.
- 3 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-22
Open AccessThree dimensional multiscalar neurovascular nephron connectivity map of the human kidney across the lifespan
The human kidney maintains homeostasis through a complex network of up to a million nephrons, its fundamental tissue units. Using innovative tissue processing and light sheet fluorescence microscopy, we mapped the 3D neurovascular connectivity of nephrons to understand how their structural organization enables coordinated functions like filtration, absorption, and blood pressure regulation. Our analysis revealed developmental changes in glomerular orientation, density, volume, and innervation from birth through aging. We discovered an extensive nerve network connecting different nephron segments and organizing glomeruli into distinct communities. These communities are linked through “mother glomeruli” that serve as control centers, creating a repeating pattern throughout the cortex. This sophisticated neural organization, which is underdeveloped in newborn kidneys and disrupted in conditions like diabetes and hydronephrosis, appears to facilitate synchronized responses to maintain fluid balance. The findings provide insights into how the kidney’s structural architecture enables coordinated function across its numerous nephrons.
- Open Access
A Multimodal Spatial and Epigenomic Atlas of Human Adult Lung Topography
Developing high-resolution reference maps of disease-susceptible spatial niches is a critical step to mitigating the profound effects of lung disease. Here, we present an integrated multimodal single-nucleus human lung atlas (snHLA) profiling 746,047 nuclei from 49 mapped lung blocks spanning clinically relevant distal airways, alveoli, and interstitium across 11 healthy adults. Integrating snRNA-seq and SNARE-seq2, which co-assays chromatin accessibility and gene expression from the same nucleus, we resolved 70 molecularly distinct populations and captured 332,846 accessible chromatin regions, nominating new transcriptional regulators of human lung cell diversity. Spatial transcriptomics using MERFISH mapped 25 cell populations across 7 structural neighborhoods and multiplexed immunofluorescence localized cell subtypes and distal airway-defining protein markers, expanding and validating distinct lung structure-specific cell populations. This open access snHLA and companion Cell Type and Marker Gene Dictionary with anatomically aligned nomenclature delivers a foundational resource at an unprecedented resolution to interrogate the origins of lung pathophysiology.
Open AccessA Multimodal Spatial and Epigenomic Atlas of Human Adult Lung Topography
Developing high-resolution reference maps of disease-susceptible spatial niches is a critical step to mitigating the profound effects of lung disease. Here, we present an integrated multimodal single-nucleus human lung atlas (snHLA) profiling 746,047 nuclei from 49 mapped lung blocks spanning clinically relevant distal airways, alveoli, and interstitium across 11 healthy adults. Integrating snRNA-seq and SNARE-seq2, which co-assays chromatin accessibility and gene expression from the same nucleus, we resolved 70 molecularly distinct populations and captured 332,846 accessible chromatin regions, nominating new transcriptional regulators of human lung cell diversity. Spatial transcriptomics using MERFISH mapped 25 cell populations across 7 structural neighborhoods and multiplexed immunofluorescence localized cell subtypes and distal airway-defining protein markers, expanding and validating distinct lung structure-specific cell populations. This open access snHLA and companion Cell Type and Marker Gene Dictionary with anatomically aligned nomenclature delivers a foundational resource at an unprecedented resolution to interrogate the origins of lung pathophysiology.
- Open Access
- 25 October 2024
- Published by Springer Nature
812.2 Lung FFPE Multiplexed Immunofluorescence Phenocycler-Fusion® Antibody Validation Protocol v1
This protocol describes validation of a 45-antibody panel used for multiplexed immunofluorescent (MxF) staining and imaging of FFPE lung tissue sections utilizing the Phenocycler-Fusion® 2.0 platform (Akoya Biosciences). The validation strategy involves staining two serial lung sections, one with a cocktail of 45 antibodies either custom (in-house) barcode-conjugated antibodies or antibody-barcoded conjugates sourced from Akoya Biosciences, and the second with the respective carrier-free, unconjugated (prior to conjugation with oligo barcode tag) control antibodies. The commercially conjugated Akoya-sourced antibodies were omitted from the second section. In addition, a section of kidney cortex was exposed to the fully conjugated antibody cocktail to confirm specificity of antibodies directed against lung specific markers, and specificity of pan-epithelial, endothelial, megakaryocyte, and immune cell markers in 2 different tissues (e.g. lung, kidney) as cross-organ, high level cell type validation. The protocol includes sections describing 1) Tissue sections, 2) Labeling with barcode-conjugated or unconjugated Ab, 3) Reporter Plate and Experimental Design, 4) Multiplexed Imaging and Image Upload to OMERO for review, and 5) Review criteria. Detailed descriptions of staining, imaging and conjugation procedures can be found in a companion protocol dx.doi.org/10.17504/protocols.io.6qpvr38dpvmk/v3.
- 25 October 2024
- Published by Springer Nature
Open Access812.2 Lung FFPE Multiplexed Immunofluorescence Phenocycler-Fusion® Antibody Validation Protocol v1
This protocol describes validation of a 45-antibody panel used for multiplexed immunofluorescent (MxF) staining and imaging of FFPE lung tissue sections utilizing the Phenocycler-Fusion® 2.0 platform (Akoya Biosciences). The validation strategy involves staining two serial lung sections, one with a cocktail of 45 antibodies either custom (in-house) barcode-conjugated antibodies or antibody-barcoded conjugates sourced from Akoya Biosciences, and the second with the respective carrier-free, unconjugated (prior to conjugation with oligo barcode tag) control antibodies. The commercially conjugated Akoya-sourced antibodies were omitted from the second section. In addition, a section of kidney cortex was exposed to the fully conjugated antibody cocktail to confirm specificity of antibodies directed against lung specific markers, and specificity of pan-epithelial, endothelial, megakaryocyte, and immune cell markers in 2 different tissues (e.g. lung, kidney) as cross-organ, high level cell type validation. The protocol includes sections describing 1) Tissue sections, 2) Labeling with barcode-conjugated or unconjugated Ab, 3) Reporter Plate and Experimental Design, 4) Multiplexed Imaging and Image Upload to OMERO for review, and 5) Review criteria. Detailed descriptions of staining, imaging and conjugation procedures can be found in a companion protocol dx.doi.org/10.17504/protocols.io.6qpvr38dpvmk/v3.
- 1 May 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 326 (5) , L604-L617
Bulk RNA sequencing of human pediatric lung cell populations reveals unique transcriptomic signature associated with postnatal pulmonary development
This study presents postnatal transcriptomic changes in major cell populations in human lung, namely endothelial, epithelial, mesenchymal cells, and leukocytes. Although human postnatal lung development continues through early adulthood, our results demonstrate that greatest transcriptional changes occur in first few months of life during neonate to infant transition. These early transcriptional changes in lung parenchyma are particularly notable for functional maturation and activation of alveolar type II cell genes.
- 1 May 2024
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 326 (5) , L604-L617
Bulk RNA sequencing of human pediatric lung cell populations reveals unique transcriptomic signature associated with postnatal pulmonary development
This study presents postnatal transcriptomic changes in major cell populations in human lung, namely endothelial, epithelial, mesenchymal cells, and leukocytes. Although human postnatal lung development continues through early adulthood, our results demonstrate that greatest transcriptional changes occur in first few months of life during neonate to infant transition. These early transcriptional changes in lung parenchyma are particularly notable for functional maturation and activation of alveolar type II cell genes.